Literature DB >> 33810885

Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis.

Cristina Mei1, Mark van der Gaag2, Barnaby Nelson1, Filip Smit3, Hok Pan Yuen1, Maximus Berger1, Marija Krcmar1, Paul French4, G Paul Amminger1, Andreas Bechdolf5, Pim Cuijpers6, Alison R Yung7, Patrick D McGorry8.   

Abstract

Intervention at the earliest illness stage, in ultra or clinical high-risk individuals, or indicated prevention, currently represents the most promising strategy to ameliorate, delay or prevent psychosis. We review the current state of evidence and conduct a broad-spectrum meta-analysis of various outcomes: transition to psychosis, attenuated positive and negative psychotic symptoms, mania, depression, anxiety, general psychopathology, symptom-related distress, functioning, quality of life, and treatment acceptability. 26 randomized controlled trials were included. Meta-analytically pooled interventions reduced transition rate (risk ratio [RR] = 0.57, 95%CI 0.41-0.81) and attenuated positive psychotic symptoms at 12-months (standardized mean difference = -0.15, 95%CI = -0.28--0.01). When stratified by intervention type (pharmacological, psychological), only the pooled effect of psychological interventions on transition rate was significant. Cognitive behavioral therapy (CBT) was associated with a reduction in incidence at 12-months (RR = 0.52, 95%CI = 0.33-0.82) and 18-48-months (RR = 0.60, 95%CI = 0.42-0.84), but not 6-months. Findings at 12-months and 18-48-months were robust in sensitivity and subgroup analyses. All other outcomes were non-significant. To date, effects of trialed treatments are specific to transition and, a lesser extent, attenuated positive symptoms, highlighting the future need to target other symptom domains and functional outcomes. Sound evidence supports CBT in reducing transition and the value of intervening at this illness stage. STUDY REGISTRATION: Research Registry ID: reviewregistry907.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive behavior therapy; Family intervention; Omega-3 fatty acid; Prevention; Psychosis; Ultra-high risk

Year:  2021        PMID: 33810885     DOI: 10.1016/j.cpr.2021.102005

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  8 in total

1.  Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis.

Authors:  Dominic Oliver; Maite Arribas; Joaquim Radua; Gonzalo Salazar de Pablo; Andrea De Micheli; Giulia Spada; Martina Maria Mensi; Magdalena Kotlicka-Antczak; Renato Borgatti; Marco Solmi; Jae Il Shin; Scott W Woods; Jean Addington; Philip McGuire; Paolo Fusar-Poli
Journal:  Mol Psychiatry       Date:  2022-06-03       Impact factor: 15.992

2.  Overoptimistic Literature and Methodological Biases Favoring Cognitive Behavioral Therapy for the Prevention of Psychosis.

Authors:  Paolo Fusar-Poli; Joaquim Radua; Cathy Davies; Sameer Jauhar
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 9.306

3.  Efficacy of a transdiagnostic, prevention-focused program for at-risk young adults: a waitlist-controlled trial.

Authors:  Nicole R DeTore; Lauren Luther; Wisteria Deng; Jordan Zimmerman; Logan Leathem; Anne S Burke; Maren B Nyer; Daphne J Holt
Journal:  Psychol Med       Date:  2022-03-01       Impact factor: 10.592

4.  Research Trends in Individuals at High Risk for Psychosis: A Bibliometric Analysis.

Authors:  Tae Young Lee; Soo Sang Lee; Byoung-Gyu Gong; Jun Soo Kwon
Journal:  Front Psychiatry       Date:  2022-04-29       Impact factor: 5.435

5.  Actionable Genomics in Clinical Practice: Paradigmatic Case Reports of Clinical and Therapeutic Strategies Based upon Genetic Testing.

Authors:  Merlin G Butler; Daniel Moreno-De-Luca; Antonio M Persico
Journal:  Genes (Basel)       Date:  2022-02-10       Impact factor: 4.096

Review 6.  Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.

Authors:  Javier-David Lopez-Morinigo; Stefan Leucht; Celso Arango
Journal:  Pharmacopsychiatry       Date:  2022-07-01       Impact factor: 2.544

7.  Transdiagnostic Psychopathology in a Help-Seeking Population of an Early Recognition Center for Mental Disorders: Protocol for an Experience Sampling Study.

Authors:  Marlene Rosen; Linda T Betz; Christian Montag; Christopher Kannen; Joseph Kambeitz
Journal:  JMIR Res Protoc       Date:  2022-08-01

8.  Application of the unified protocol for the transdiagnostic treatment of comorbid emotional disorders in patients with ultra-high risk of developing psychosis: A randomized trial study protocol.

Authors:  Trinidad Peláez; Raquel López-Carrillero; Marta Ferrer-Quintero; Susana Ochoa; Jorge Osma
Journal:  Front Psychol       Date:  2022-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.